Published in J Clin Microbiol on May 01, 1995
Microorganisms resistant to free-living amoebae. Clin Microbiol Rev (2004) 4.22
Emergence of the ehrlichioses as human health problems. Emerg Infect Dis (1996) 3.89
Nested PCR assay for detection of granulocytic ehrlichiae. J Clin Microbiol (1998) 3.15
PCR amplification and comparison of nucleotide sequences from the groESL heat shock operon of Ehrlichia species. J Clin Microbiol (1997) 2.59
Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. J Clin Microbiol (1998) 2.44
Hemocytic rickettsia-like organisms in ticks: serologic reactivity with antisera to Ehrlichiae and detection of DNA of agent of human granulocytic ehrlichiosis by PCR. J Clin Microbiol (1995) 2.38
Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J Clin Microbiol (1995) 2.32
An indirect immunofluorescence assay using a cell culture-derived antigen for detection of antibodies to the agent of human granulocytic ehrlichiosis. J Clin Microbiol (1997) 2.32
Geographic, clinical, serologic, and molecular evidence of granulocytic ehrlichiosis, a likely zoonotic disease, in Minnesota and Wisconsin dogs. J Clin Microbiol (1996) 2.14
ankA: an Ehrlichia phagocytophila group gene encoding a cytoplasmic protein antigen with ankyrin repeats. Infect Immun (2000) 2.02
Comparison of major antigenic proteins of six strains of the human granulocytic ehrlichiosis agent by Western immunoblot analysis. J Clin Microbiol (1997) 1.98
Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response. Infect Immun (1998) 1.92
Isolation of the equine granulocytic ehrlichiosis agent, Ehrlichia equi, in tick cell culture. J Clin Microbiol (1996) 1.79
Major antigenic proteins of the agent of human granulocytic ehrlichiosis are encoded by members of a multigene family. Infect Immun (1998) 1.72
Natural infection of small mammal species in Minnesota with the agent of human granulocytic ehrlichiosis. J Clin Microbiol (1997) 1.70
Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota. J Clin Microbiol (1996) 1.70
Protection against Ehrlichia equi is conferred by prior infection with the human granulocytotropic Ehrlichia (HGE agent). J Clin Microbiol (1995) 1.70
Serologic evidence of human monocytic and granulocytic ehrlichiosis in Israel. Emerg Infect Dis (2000) 1.68
Equine granulocytic ehrlichiosis in Connecticut caused by an agent resembling the human granulocytotropic ehrlichia. J Clin Microbiol (1996) 1.64
Serologic testing for human granulocytic ehrlichiosis at a national referral center. J Clin Microbiol (1999) 1.58
Molecular cloning and sequencing of three granulocytic Ehrlichia genes encoding high-molecular-weight immunoreactive proteins. Infect Immun (1998) 1.50
Inter- and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by the immunofluorescent-antibody test. J Clin Microbiol (1999) 1.45
Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum. Clin Microbiol Rev (2011) 1.44
Serological responses to Ehrlichia equi, Ehrlichia chaffeensis, and Borrelia burgdorferi in patients from New York State. J Clin Microbiol (1997) 1.41
Human granulocytic ehrlichiosis in southern Germany: increased seroprevalence in high-risk groups. J Clin Microbiol (1997) 1.40
A 16S rRNA-based PCR assay for detection and identification of granulocytic Ehrlichia species in dogs, horses, and cattle. J Clin Microbiol (1996) 1.37
Comparison of the nucleotide sequences of 16S rRNA, 444 Ep-ank, and groESL heat shock operon genes in naturally occurring Ehrlichia equi and human granulocytic ehrlichiosis agent isolates from Northern California. J Clin Microbiol (2000) 1.36
Serological investigation of granulocytic Ehrlichia infection in sheep in Norway. Acta Vet Scand (2001) 1.35
Serology of culture-confirmed cases of human granulocytic ehrlichiosis. J Clin Microbiol (2000) 1.32
Serologic evidence of infection with Ehrlichia spp. in wild rodents (Muridae: Sigmodontinae) in the United States. J Clin Microbiol (1998) 1.32
The agent of Human Granulocytic Ehrlichiosis resides in an endosomal compartment. J Clin Invest (1998) 1.31
Infection with agents of human granulocytic ehrlichiosis, lyme disease, and babesiosis in wild white-footed mice (Peromyscus leucopus) in Connecticut. J Clin Microbiol (1999) 1.31
Human exposure to a granulocytic Ehrlichia and other tick-borne agents in Connecticut. J Clin Microbiol (1998) 1.30
Major surface protein 2 of Anaplasma phagocytophilum facilitates adherence to granulocytes. Infect Immun (2003) 1.29
Molecular evidence of coinfection of ticks with Borrelia burgdorferi sensu lato and the human granulocytic ehrlichiosis agent in Switzerland. J Clin Microbiol (1999) 1.27
Serologic and molecular detection of granulocytic ehrlichiosis in Rhode Island. J Clin Microbiol (1997) 1.26
Differences in clinical manifestations and hematological and serological responses after experimental infection with genetic variants of Anaplasma phagocytophilum in sheep. Clin Diagn Lab Immunol (2003) 1.22
Serologic and molecular detection of Ehrlichia chaffeensis and Anaplasma phagocytophila (human granulocytic ehrlichiosis agent) in Korean patients. J Clin Microbiol (2002) 1.22
Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins. Antimicrob Agents Chemother (1997) 1.17
Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates. J Clin Microbiol (1998) 1.17
Characterization of an immunoreactive protein from the agent of human granulocytic ehrlichiosis. J Clin Microbiol (1997) 1.17
Improved sensitivity of PCR for diagnosis of human granulocytic ehrlichiosis using epank1 genes of Ehrlichia phagocytophila-group ehrlichiae. J Clin Microbiol (2000) 1.16
Gray foxes (Urocyon cinereoargenteus) as a potential reservoir of a Bartonella clarridgeiae-like bacterium and domestic dogs as part of a sentinel system for surveillance of zoonotic arthropod-borne pathogens in northern California. J Clin Microbiol (2007) 1.15
Serological evidence of human granulocytic ehrlichiosis in Switzerland. Eur J Clin Microbiol Infect Dis (1998) 1.11
Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J Clin Microbiol (2002) 1.11
Serodiagnosis of human granulocytic ehrlichiosis by using novel combinations of immunoreactive recombinant proteins. J Clin Microbiol (2001) 1.10
Serologic evidence of a natural infection of white-tailed deer with the agent of human granulocytic ehrlichiosis in Wisconsin and Maryland. Clin Diagn Lab Immunol (1998) 1.09
Disparity in the natural cycles of Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis. Emerg Infect Dis (1999) 1.09
Detection of antibodies to Anaplasma phagocytophilum and Ehrlichia chaffeensis antigens in sera of Korean patients by western immunoblotting and indirect immunofluorescence assays. Clin Diagn Lab Immunol (2003) 1.09
Genetic variability and stability of Anaplasma phagocytophila msp2 (p44). Infect Immun (2002) 1.08
Anaplasma phagocytophilum infection in small mammal hosts of Ixodes ticks, western United States. Emerg Infect Dis (2008) 1.08
Immunity reduces reservoir host competence of Peromyscus leucopus for Ehrlichia phagocytophila. Infect Immun (2000) 1.07
Reduced weight gain due to subclinical Anaplasma phagocytophilum (formerly Ehrlichia phagocytophila) infection. Exp Appl Acarol (2002) 1.05
Evidence of the human granulocytic ehrlichiosis agent in Ixodes ricinus ticks in Switzerland. J Clin Microbiol (1999) 1.03
Anaplasma phagocytophilum p44 mRNA expression is differentially regulated in mammalian and tick host cells: involvement of the DNA binding protein ApxR. J Bacteriol (2007) 1.00
Recombinant major antigenic protein 2 of Ehrlichia canis: a potential diagnostic tool. J Clin Microbiol (2001) 0.98
Seroprevalence of Ehrlichia canis and of canine granulocytic Ehrlichia infection in dogs in Switzerland. J Clin Microbiol (1998) 0.96
Western blot analysis of sera reactive to human monocytic ehrlichiosis and human granulocytic ehrlichiosis agents. J Clin Microbiol (2001) 0.96
Reservoir competence of the redwood chipmunk (Tamias ochrogenys) for Anaplasma phagocytophilum. Vector Borne Zoonotic Dis (2009) 0.94
Differences in the transmissibility of two Anaplasma phagocytophilum strains by the North American tick vector species, Ixodes pacificus and Ixodes scapularis (Acari: Ixodidae). Exp Appl Acarol (2006) 0.93
Isolation of the etiologic agent of human granulocytic ehrlichiosis from the white-footed mouse (Peromyscus leucopus). J Clin Microbiol (2001) 0.93
Comparison of two recombinant major outer membrane proteins of the human granulocytic ehrlichiosis agent for use in an enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (2000) 0.90
Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States. Antimicrob Agents Chemother (2003) 0.90
Use of serum C-reactive protein as an early marker of inflammatory activity in canine type II immune-mediated polyarthritis: case report. Acta Vet Scand (2006) 0.88
Sequential analysis of Anaplasma phagocytophilum msp2 transcription in murine and equine models of human granulocytic anaplasmosis. Clin Vaccine Immunol (2007) 0.88
Unidirectional suppression of Anaplasma phagocytophilum genotypes in infected lambs. Clin Diagn Lab Immunol (2005) 0.88
Molecular characterization of Ehrlichia interactions with tick cells and macrophages. Front Biosci (Landmark Ed) (2009) 0.85
Analysis of seroreactivity against cell culture-derived Bartonella spp. antigens in dogs. J Vet Intern Med (2013) 0.84
Heat shock protein 70 of the agent of human granulocytic ehrlichiosis binds to Borrelia burgdorferi antibodies. Clin Diagn Lab Immunol (1998) 0.84
Anaplasma phagocytophilum infection in north Norway. The first laboratory confirmed case. Acta Vet Scand (2005) 0.83
Serological evidence for human granulocytic ehrlichiosis in Western Austria. Eur J Clin Microbiol Infect Dis (2003) 0.83
Superinfection occurs in Anaplasma phagocytophilum infected sheep irrespective of infection phase and protection status. Acta Vet Scand (2009) 0.83
Prevalence of Anaplasma phagocytophilum infection and effect on lamb growth. Acta Vet Scand (2011) 0.82
A comparative study of clinical manifestations, haematological and serological responses after experimental infection with Anaplasma phagocytophilum in two Norwegian sheep breeds. Acta Vet Scand (2011) 0.81
Persistence of Ehrlichia phagocytophila infection in two age groups of lambs. Acta Vet Scand (2001) 0.81
Persistence of granulocytic Ehrlichia infection during wintertime in two sheep flocks in Norway. Acta Vet Scand (2001) 0.80
Serological evidence of infection with Ehrlichia spp. in red foxes (Vulpes vulpes) in Switzerland. J Clin Microbiol (1999) 0.80
Isolation and characterization of two European strains of Ehrlichia phagocytophila of equine origin. Clin Diagn Lab Immunol (2002) 0.79
Infection of laboratory mice with the human granulocytic ehrlichiosis agent does not induce antibodies to diagnostically significant Borrelia burgdorferi antigens. J Clin Microbiol (1999) 0.79
The effect of two different oxytetracycline treatments in experimental Ehrlichia phagocytophila infected lambs. Acta Vet Scand (2001) 0.76
Cloning of the major outer membrane protein expression locus in Anaplasma platys and seroreactivity of a species-specific antigen. J Bacteriol (2011) 0.76
Human granulocytic ehrlichiosis agent infection in a pony vaccinated with a Borrelia burgdorferi recombinant OspA vaccine and challenged by exposure to naturally infected ticks. Clin Diagn Lab Immunol (2000) 0.75
The ecology of tick-transmitted infections in the redwood chipmunk (Tamias ochrogenys). Ticks Tick Borne Dis (2011) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol (1994) 9.97
Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J Clin Microbiol (1991) 8.36
Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA (1994) 6.55
The tribe Ehrlichieae and ehrlichial diseases. Clin Microbiol Rev (1991) 5.87
Serologic diagnosis of human ehrlichiosis using two Ehrlichia canis isolates. J Infect Dis (1991) 3.68
Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern Med (1994) 3.62
Experimentally induced infection of dogs, cats, and nonhuman primates with Ehrlichia equi, etiologic agent of equine ehrlichiosis. Am J Vet Res (1975) 2.67
Equine ehrlichiosis. J Am Vet Med Assoc (1969) 2.57
Analyses of Ehrlichia canis and a canine granulocytic Ehrlichia infection. J Clin Microbiol (1992) 2.57
Studies on the infectious agent of tick-borne fever in sheep. J Pathol Bacteriol (1951) 2.49
Identification of the antigenic constituents of Ehrlichia chaffeensis. Am J Trop Med Hyg (1994) 2.13
Seroepidemiologic survey of antibodies to Ehrlichia equi in horses of northern California. J Am Vet Med Assoc (1990) 1.89
Antigenic analysis of four species of the genus Ehrlichia by use of protein immunoblot. Am J Vet Res (1991) 1.80
Antigenic characterization of ehrlichiae: protein immunoblotting of Ehrlichia canis, Ehrlichia sennetsu, and Ehrlichia risticii. J Clin Microbiol (1992) 1.74
Suspected ehrlichiosis in a gelding in Wales. Vet Rec (1989) 1.66
Ehrlichia chaffeensis expresses an immunoreactive protein homologous to the Escherichia coli GroEL protein. Infect Immun (1993) 1.62
Infection in two dogs with an agent resembling Ehrlichia equi. J Am Vet Med Assoc (1982) 1.52
A serological survey of Ehrlichia canis, Ehrlichia equi, Rickettsia rickettsii, and Borrelia burgdorferi in dogs in Oklahoma. J Vet Diagn Invest (1989) 1.37
Antigenic and genomic relatedness among Ehrlichia risticii, Ehrlichia sennetsu, and Ehrlichia canis. Int J Syst Bacteriol (1992) 1.14
Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol (1994) 9.97
A critical appraisal of "chronic Lyme disease". N Engl J Med (2007) 7.84
Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med (1996) 5.35
Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J Infect Dis (1995) 5.26
Ehrlichial diseases of humans: emerging tick-borne infections. Clin Infect Dis (1995) 3.12
A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coli. J Infect Dis (1990) 2.63
Nested polymerase chain reaction for detection of Ehrlichia equi genomic DNA in horses and ticks (Ixodes pacificus). Vet Parasitol (1996) 2.51
Transmission and passage in horses of the agent of human granulocytic ehrlichiosis. J Infect Dis (1995) 2.31
Antigenic diversity of granulocytic Ehrlichia isolates from humans in Wisconsin and New York and a horse in California. J Infect Dis (1997) 2.31
Human ehrlichioses: newly recognized infections transmitted by ticks. Annu Rev Med (1998) 2.25
Geographic, clinical, serologic, and molecular evidence of granulocytic ehrlichiosis, a likely zoonotic disease, in Minnesota and Wisconsin dogs. J Clin Microbiol (1996) 2.14
ankA: an Ehrlichia phagocytophila group gene encoding a cytoplasmic protein antigen with ankyrin repeats. Infect Immun (2000) 2.02
Equine ehrlichiosis in northern California: 49 cases (1968-1981). J Am Vet Med Assoc (1987) 2.01
[Primary and secondary negative symptoms: a useful differentiation? An empirical study]. Nervenarzt (1996) 2.01
Ixodes pacificus (Acari: Ixodidae) as a vector of Ehrlichia equi (Rickettsiales: Ehrlichieae). J Med Entomol (1996) 1.89
Antimicrobial susceptibilities of equine isolates of Clostridium difficile and molecular characterization of metronidazole-resistant strains. Clin Infect Dis (1997) 1.85
Isolation of the equine granulocytic ehrlichiosis agent, Ehrlichia equi, in tick cell culture. J Clin Microbiol (1996) 1.79
Human granulocytic ehrlichiosis in Wisconsin and Minnesota: a frequent infection with the potential for persistence. J Infect Dis (1996) 1.79
Escherichia coli 987P pilus: purification and partial characterization. J Bacteriol (1981) 1.78
Major antigenic proteins of the agent of human granulocytic ehrlichiosis are encoded by members of a multigene family. Infect Immun (1998) 1.72
Protection against Ehrlichia equi is conferred by prior infection with the human granulocytotropic Ehrlichia (HGE agent). J Clin Microbiol (1995) 1.70
Comparative pathology, and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections. Am J Trop Med Hyg (2000) 1.55
Selective ceftazidime resistance in Escherichia coli: association with changes in outer membrane protein. J Infect Dis (1987) 1.55
Isolation and characterization of a new strain of Ehrlichia chaffeensis from a patient with nearly fatal monocytic ehrlichiosis. J Clin Microbiol (1995) 1.54
Quantitative real-time PCR for detection of members of the Ehrlichia phagocytophila genogroup in host animals and Ixodes ricinus ticks. J Clin Microbiol (1999) 1.53
Abnormal plasma neuroactive progestagen derivatives in ill, neonatal foals presented to the neonatal intensive care unit. Equine Vet J (2013) 1.47
Inter- and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by the immunofluorescent-antibody test. J Clin Microbiol (1999) 1.45
Use of a gonadotrophin-releasing hormone vaccine in headshaking horses. Vet Rec (2010) 1.44
Measurement of plasma colloid osmotic pressure in normal thoroughbred neonatal foals. J Vet Intern Med (2001) 1.43
Laser-assisted lead extraction: the European experience. Europace (2007) 1.41
Equine protozoal myeloencephalitis. Vet Clin North Am Equine Pract (1987) 1.40
Cerebral oedema and cerebellar herniation in four equine neonates. Equine Vet J (1992) 1.39
Comparison of the nucleotide sequences of 16S rRNA, 444 Ep-ank, and groESL heat shock operon genes in naturally occurring Ehrlichia equi and human granulocytic ehrlichiosis agent isolates from Northern California. J Clin Microbiol (2000) 1.36
Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study). Clin Genet (2006) 1.29
Serum cytokine responses during acute human granulocytic ehrlichiosis. Clin Diagn Lab Immunol (2000) 1.29
Effect of chlorambucil on spermatogenesis in the human with malignant lymphoma. Cancer (1970) 1.29
Penetration of amoxicillin and potassium clavulanate into the cerebrospinal fluid of patients with inflamed meninges. Antimicrob Agents Chemother (1986) 1.27
Anorectal sphincter function and rectal barostat study in patients following transanal endoscopic microsurgery. Int J Colorectal Dis (2001) 1.25
Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19). J Cancer Res Clin Oncol (2005) 1.22
An Ehrlichia strain from a llama (Lama glama) and Llama-associated ticks (Ixodes pacificus). J Clin Microbiol (1997) 1.21
Human granulocytic ehrlichiosis in Northern California: two case descriptions with genetic analysis of the Ehrlichiae. Clin Infect Dis (1999) 1.18
Comparison of bacteriologic culture of blood and necropsy specimens for determining the cause of foal septicemia: 47 cases (1978-1987) J Am Vet Med Assoc (1989) 1.18
Ehrlichia phagocytophila genogroup rickettsiae in ixodid ticks from California collected in 1995 and 1996. J Clin Microbiol (1997) 1.17
Improved sensitivity of PCR for diagnosis of human granulocytic ehrlichiosis using epank1 genes of Ehrlichia phagocytophila-group ehrlichiae. J Clin Microbiol (2000) 1.16
Experimental transmission of Ehrlichia equi to horses through naturally infected ticks (Ixodes pacificus) from Northern California. J Clin Microbiol (1998) 1.14
Quantitative evaluation of ehrlichial burden in horses after experimental transmission of human granulocytic Ehrlichia agent by intravenous inoculation with infected leukocytes and by infected ticks. J Clin Microbiol (1999) 1.14
Anorectal lymphadenopathy causing colic, perirectal abscesses, or both in five young horses. J Am Vet Med Assoc (1997) 1.13
Risk factors for Lyme disease in a small rural community in northern California. Am J Epidemiol (1992) 1.12
Serological evidence of human granulocytic ehrlichiosis in Switzerland. Eur J Clin Microbiol Infect Dis (1998) 1.11
Production and characterization of Ehrlichia risticii, the agent of Potomac horse fever, from snails (Pleuroceridae: Juga spp.) in aquarium culture and genetic comparison to equine strains. J Clin Microbiol (1998) 1.11
Helminthic transmission and isolation of Ehrlichia risticii, the causative agent of Potomac horse fever, by using trematode stages from freshwater stream snails. J Clin Microbiol (2000) 1.10
Simultaneous determination of chlordiazepoxide and clidinium bromide in pharmaceutical formulations by derivative spectrophotometry. Int J Pharm (1999) 1.10
Serologic evidence of a natural infection of white-tailed deer with the agent of human granulocytic ehrlichiosis in Wisconsin and Maryland. Clin Diagn Lab Immunol (1998) 1.09
Nested polymerase chain reaction for detection of Ehrlichia risticii genomic DNA in infected horses. Vet Parasitol (1997) 1.09
Analysis of genetic identity of North American Anaplasma phagocytophilum strains by pulsed-field gel electrophoresis. J Clin Microbiol (2003) 1.06
Detection of Ehrlichia risticii, the agent of Potomac horse fever, in freshwater stream snails (Pleuroceridae: Juga spp.) from northern California. Appl Environ Microbiol (1998) 1.06
Evaluation of the haemostatic profile in the pre- and post parturient mare, with particular focus on the perinatal period. Equine Vet J (1992) 1.05
Determination of tar, nicotine, and carbon monoxide yields in the mainstream smoke of selected international cigarettes. Tob Control (2004) 1.05
Interlaboratory and intralaboratory comparisons of indirect immunofluorescence assays for serodiagnosis of Lyme disease. J Clin Microbiol (1990) 1.03
Spatial distribution of seropositivity to the causative agent of granulocytic ehrlichiosis in dogs in California. Am J Vet Res (2001) 1.02
Photodynamic control of human pathogenic parasites in aquatic ecosystems using chlorophyllin and pheophorbid as photodynamic substances. Parasitol Res (2008) 1.02
Serologic and molecular evidence of Ehrlichia spp. in coyotes in California. J Wildl Dis (2000) 1.02
Granulocytic ehrlichiosis and tick infestation in mountain lions in California. J Wildl Dis (1999) 1.01
Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation reaction and C-reactive protein. Scand J Clin Lab Invest (1984) 1.01
Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and the Baltic States. J Med Genet (2002) 1.00
Experimental inoculation with human granulocytic Ehrlichia agent derived from high- and low-passage cell culture in horses. J Clin Microbiol (2000) 0.98
Intraoperative microwave ablation for curative treatment of atrial fibrillation in open heart surgery--the MICRO-STAF and MICRO-PASS pilot trial. MICROwave Application in Surgical treatment of Atrial Fibrillation. MICROwave Application for the Treatment of Atrial Fibrillation in Bypass-Surgery. Thorac Cardiovasc Surg (1999) 0.98
Spatial differences of the duration of ventricular late fields in the signal-averaged magnetocardiogram in patients with ventricular late potentials. Pacing Clin Electrophysiol (1993) 0.95
Ehrlichia equi infection in a foal. J Am Vet Med Assoc (1987) 0.95
[Chronopathology of endogenous depressions]. Nervenarzt (1984) 0.95
A simian model of human granulocytic ehrlichiosis. Am J Trop Med Hyg (1999) 0.94
Pedigree analysis and exclusion of alpha-tocopherol transfer protein (TTPA) as a candidate gene for neuroaxonal dystrophy in the American Quarter Horse. J Vet Intern Med (2012) 0.94
Chlorophyllin for the control of Ichthyophthirius multifiliis (Fouquet). Parasitol Res (2012) 0.94
Detection of Leptospira spp. in the aqueous humor of horses with naturally acquired recurrent uveitis. J Clin Microbiol (2000) 0.93
Infection of aquatic insects with trematode metacercariae carrying Ehrlichia risticii, the cause of Potomac horse fever. J Med Entomol (2000) 0.93
Association of Ixodes pacificus (Acari: ixodidae) with the spatial and temporal distribution of equine granulocytic ehrlichiosis in California. J Med Entomol (1999) 0.93
Environmental exposures that affect the endocrine system: public health implications. J Toxicol Environ Health B Crit Rev (1998) 0.92
Magnetocardiography: three-dimensional localization of the origin of ventricular late fields in the signal averaged magnetocardiogram in patients with ventricular late potentials. Eur Heart J (1993) 0.91
Physical characterization of gravitaxis in Euglena gracilis. J Plant Physiol (1999) 0.91
Equine degenerative myeloencephalopathy in Lusitano horses. J Vet Intern Med (2011) 0.91
Health evaluation of 1,4-dioxane. Toxicol Ind Health (1996) 0.90
Digenetic trematodes, Acanthatrium sp. and Lecithodendrium sp., as vectors of Neorickettsia risticii, the agent of Potomac horse fever. J Helminthol (2003) 0.90
[Time perception and time estimation in depressive patients]. Nervenarzt (1998) 0.90
Dexamethasone-induced cytokine changes associated with diminished disease severity in horses infected with Anaplasma phagocytophilum. Clin Vaccine Immunol (2011) 0.89
Bronchointerstitial pneumonia and respiratory distress in young horses: clinical, clinicopathologic, radiographic, and pathological findings in 23 cases (1984-1989). J Vet Intern Med (1994) 0.89
Detection and quantitation of Ehrlichia risticii genomic DNA in infected horses and snails by real-time PCR. Vet Parasitol (2000) 0.89
Ehrlichia spp. in cervids from California. J Wildl Dis (1998) 0.89
Sleep related breathing disorders in patients with ischemic stroke and transient ischemic attacks: respiratory and clinical correlations. J Physiol Pharmacol (2007) 0.87
Apparent outbreaks of Clostridium difficile-associated diarrhea in horses in a veterinary medical teaching hospital. J Vet Diagn Invest (1995) 0.86
An open study of the efficacy of a single dose of ciprofloxacin in eliminating the chronic nasopharyngeal carriage of Neisseria meningitidis. J Infect Dis (1988) 0.86
Kinetic and safety studies on intrathecally infused recombinant-methionyl human brain-derived neurotrophic factor in dogs. Fundam Appl Toxicol (1997) 0.86